Back to Trades
Wang Lai
PresidentGlobal Head of R&DCIK 0001852291
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 8
- Buy transactions
- 0
- Sell transactions
- 11
- Companies
- 1
- Active
- 2025–2026
Across 8 filings between 2025–2026, Wang Lai, President, Global Head of R&D, has disclosed $4.4M in transactions — all concentrated in BeOne Medicines Ltd. (ONC). Their disclosed trades are heavily weighted toward selling — $0 in buys and $4.4M in sells. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
8 loaded
| Jun 25 | ONC BeOne Medicines Ltd. | Wang Lai | President, Global Head of R&D | Sell | $295.6K |
| Jun 18 | ONC BeOne Medicines Ltd. | Wang Lai | President, Global Head of R&D | Sell | $310.2K |
| Jun 15 | ONC BeOne Medicines Ltd. | Wang Lai | President, Global Head of R&D | Sell | $197.3K |
| Jun 10 | ONC BeOne Medicines Ltd. | Wang Lai | President, Global Head of R&D | Sell | $368.2K |
| Mar 10 | ONC BeOne Medicines Ltd. | Wang Lai | President, Global Head of R&D | Grant | $0 |
| Sep 11 | ONC BeOne Medicines Ltd. | Wang Lai | Global Head of R&D | Sell | $1.8M |
| Jul 31 | ONC BeOne Medicines Ltd. | Wang Lai | Global Head of R&D | Sell | $1.3M |
| Jul 22 | ONC BeOne Medicines Ltd. | Wang Lai | Global Head of R&D | Sell | $210.0K |
8 filings